Merck & Co. Inc., MRK is in the exchange NYSE and its industry is Drug Manufacturers – Major in the sector of Healthcare. Based in USA, Merck & Co. Inc., MRK has a market cap of 160725.56. Since its IPO date on the 01/02/1970, Merck & Co. Inc., MRK performance year to date is 11.56%. Today Merck & Co. Inc., MRK has gained 0.11%, with a current price of 58.
Ownership of the company is 0.04% for insider ownership while institutional ownership is 74.90%. The management of the company have seen the company have a payout ratio of 110.40%. Return of assets are at 4.60%, with return on investment at 6.40%.
In terms of debt levels and profit levels, Merck & Co. Inc., MRK is seeing a long-term debt/equity of 0.54. While Total debt/equity is 0.59. With a profit margin of 11.70%, this is combined with a gross margin of 62.80%, and operating margin of 18.20%. Merck & Co. Inc. ability to meet debt levels, with a current ratio of 1.6, while the quick ratio is 1.3.
For the last year Merck & Co. Inc., MRK has seen a EPS growth of -61.60%. A performance for the year of 3.94%. The 52-week high is -0.10%, and the 52-week low is 31.34%. The average volume for Merck & Co. Inc., MRK is 3863810.
With a target price of 61.45, can Merck & Co. Inc., MRK reach this target? Looking at the value indicators of Merck & Co. Inc., MRK. Merck & Co. Inc. has a P/E of 35.44 and a forward P/E of 15.41. Perhaps the more useful indicator than P/E, is PEG which has a value of 10.58. Merck & Co. Inc. also has a P/S and a P/B of 4.08 and 3.67 respectively. For P/cash, Merck & Co. Inc. has a value of 12.42, while it is 27.62 for P/free cash flow.
At the current price of 58, Merck & Co. Inc. has a dividend yield of 3.18%. We see a return on equity of 10.20%.
Looking more long-term Merck & Co. Inc., is projected to get an EPS growth for the next five years of 3.35%. In the short-term an EPS growth of 1.13% in the next year is forecasted. This is after a EPS growth of -61.60% for this year and for the last five years a 41.50% growth has been seen.